Healthcare ❯Pharmaceuticals ❯Drug Approval ❯NHS Policies

Cost of Treatment

NICE Poised to Reject NHS Coverage for Breakthrough Alzheimer’s Drugs

NICE determined that the modest delay in Alzheimer’s progression does not justify the treatments’ high price

NHS Declines Coverage for Groundbreaking Alzheimer's Drug Due to High Costs